Advanced Neurosciences Institute

Recent papers from Advanced Neurosciences Institute

1. Clinical and immunological features of rheumatoid arthritis patients with positive anti-centromere antibody: a case-control studyFrontiers in Medicine · 2026
2. Successful hemilaminectomy in a 450‐g bearded emperor tamarin ( Sanguinus imperator subgrisescens ) with monoparesis associated with an extradural spinal haematomaVeterinary Record Case Reports · 2026
3. Concentrations of trace elements in the hair of different colours and different sampling locations in veal calvesJournal of Dairy Research · 2026
4. System recovery of MIMO nonlinear systems against false data injection attackPeerJ Computer Science · 2025
5. Mitochondrial Fitness Science Communication: A Qualitative StudyJournal of the American Geriatrics Society · 2025
6. Diroximel Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis: NEDA-3 After Re-Baselining in the Phase 3 EVOLVE-MS-1 StudyAdvances in Therapy · 2024
7. Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosisNeuroImage Clinical · 2024
8. F198S Gerstmann-Sträussler-Scheinker Syndrome With Parkinsonism, Dyskinesia, and Abnormal (I-123)-FP-CIT Single-Photon Emission Computed Tomography: A Case ReportCureus · 2023
9. Integrating Online Blog in Teaching English Creative WritingSeshiski Southeast Journal of Language and Literary Studies · 2023
10. Integrating Online Blog in Teaching English Creative WritingSeshiski Southeast Journal of Language and Literary Studies · 2023
11. Electrocardiographic measures of repolarization heterogeneity are not predictive for Torsades de Pointes among undifferentiated patients with prolonged QTc: A case control studyJournal of Cardiovascular Electrophysiology · 2022
12. Arbaclofen extended-release tablets for spasticity in multiple sclerosis: randomized, controlled clinical trialBrain Communications · 2022
13. One Drop Improves Productivity for Workers With Type 2 DiabetesJournal of Occupational and Environmental Medicine · 2022
14. Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 StudyAdvances in Therapy · 2022
15. IM Normae: The Death Spiral of a Cataclysmic Variable?The Astrophysical Journal · 2022
16. Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple SclerosisClinicoEconomics and Outcomes Research · 2021
17. Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of the CARE-MS StudiesNeurology and Therapy · 2021
18. Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosisDrugs in Context · 2020
19. Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile EffectsDrugs · 2020
20. Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension StudyCNS Drugs · 2020